WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., a commercial-stage, innovative molecular information company that sells proprietary genomic diagnostic and drug metabolism assays for pediatric neurology disorders, announced today the appointment of Thomas Fairfield to the company’s Board of Directors.
“Tom has a wealth of legal, M&A, and operating experience,” states Brian McKernan, Chief Executive Officer of Courtagen. “We look forward to adding Tom’s valuable perspectives to our Board of Directors.”
Help employers find you! Check out all the jobs and post your resume.
“Tom has a wealth of legal, M&A, and operating experience,” states Brian McKernan, Chief Executive Officer of Courtagen. “We look forward to adding Tom’s valuable perspectives to our Board of Directors.”
Help employers find you! Check out all the jobs and post your resume.
